Source: American Journal of Physiology : Endocrinology and Metabolism. Unidade: FMRP
Subjects: PROTEÍNAS MUSCULARES (MEDICAMENTOS), SISTEMA MUSCULOSQUELÉTICO, METABOLISMO DE PROTEÍNA
ABNT
BAVIERA, Amanda Martins et al. Pentoxifylline inhibits 'Ca POT. 2+'-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats. American Journal of Physiology : Endocrinology and Metabolism, v. 292, p. E702-E708, 2007Tradução . . Disponível em: https://doi.org/10.1152/ajpendo.00147.2006. Acesso em: 11 nov. 2024.APA
Baviera, A. M., Zanon, N. M., Navegantes, L. C. C., Migliorini, R. H., & Kettelhut, I. do C. (2007). Pentoxifylline inhibits 'Ca POT. 2+'-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats. American Journal of Physiology : Endocrinology and Metabolism, 292, E702-E708. doi:10.1152/ajpendo.00147.2006NLM
Baviera AM, Zanon NM, Navegantes LCC, Migliorini RH, Kettelhut I do C. Pentoxifylline inhibits 'Ca POT. 2+'-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats [Internet]. American Journal of Physiology : Endocrinology and Metabolism. 2007 ; 292 E702-E708.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1152/ajpendo.00147.2006Vancouver
Baviera AM, Zanon NM, Navegantes LCC, Migliorini RH, Kettelhut I do C. Pentoxifylline inhibits 'Ca POT. 2+'-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats [Internet]. American Journal of Physiology : Endocrinology and Metabolism. 2007 ; 292 E702-E708.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1152/ajpendo.00147.2006